$124 Million is the total value of Velan Capital Investment Management LP's 30 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 38.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | ALIMERA SCIENCES INC | $42,186,452 | +770.5% | 13,608,533 | +720.0% | 34.02% | +656.1% | |
PRAX | PRAXIS PRECISION MEDICINES I | $8,866,350 | +48.7% | 5,185,000 | 0.0% | 7.15% | +29.1% | |
JASPER THERAPEUTICS INC | $7,586,797 | -48.9% | 11,219,036 | 0.0% | 6.12% | -55.6% | ||
HRTX | Buy | HERON THERAPEUTICS INC | $7,196,346 | +37.9% | 6,986,744 | +55.3% | 5.80% | +19.7% |
ADMA | Sell | ADMA BIOLOGICS INC | $6,215,238 | -38.2% | 1,736,100 | -36.3% | 5.01% | -46.3% |
TELA | TELA BIO INC | $5,968,696 | -21.0% | 746,087 | 0.0% | 4.81% | -31.4% | |
QIPT | Buy | QUIPT HOME MEDICAL CORP | $5,599,000 | +8.1% | 1,100,000 | +13.4% | 4.52% | -6.1% |
LNTH | Sell | LANTHEUS HLDGS INC | $5,211,000 | -37.9% | 75,000 | -25.0% | 4.20% | -46.1% |
OPTN | OPTINOSE INC | $4,424,139 | 0.0% | 3,596,861 | 0.0% | 3.57% | -13.1% | |
MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $3,152,100 | +11.8% | 55,300 | 0.0% | 2.54% | -2.9% | ||
INSP | New | INSPIRE MED SYS INC | $3,036,132 | – | 15,300 | +100.0% | 2.45% | – |
IMGN | IMMUNOGEN INC | $3,007,365 | -15.9% | 189,500 | 0.0% | 2.43% | -26.9% | |
NSPR | INSPIREMD INC | $2,956,175 | +30.3% | 904,029 | 0.0% | 2.38% | +13.1% | |
GOSS | New | GOSSAMER BIO INC | $2,552,645 | – | 3,065,136 | +100.0% | 2.06% | – |
CABA | Sell | CABALETTA BIO INC | $2,283,000 | -29.3% | 150,000 | -40.0% | 1.84% | -38.6% |
APLS | New | APELLIS PHARMACEUTICALS INC | $1,902,000 | – | 50,000 | +100.0% | 1.53% | – |
GERN | GERON CORP | $1,650,420 | -34.0% | 778,500 | 0.0% | 1.33% | -42.6% | |
THC | Sell | TENET HEALTHCARE CORP | $1,643,099 | -61.1% | 24,937 | -52.0% | 1.32% | -66.2% |
ICOSAVAX INC | $1,244,883 | -22.0% | 160,630 | 0.0% | 1.00% | -32.2% | ||
New | ASLAN PHARMACEUTICALS LTDspon ads new | $1,175,000 | – | 625,000 | +100.0% | 0.95% | – | |
IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $1,137,500 | – | 250,000 | +100.0% | 0.92% | – |
ANNX | ANNEXON INC | $1,085,001 | -33.0% | 459,746 | 0.0% | 0.88% | -41.8% | |
EDSA | EDESA BIOTECH INC | $809,981 | -22.1% | 1,281,615 | 0.0% | 0.65% | -32.3% | |
CGEM | Buy | CULLINAN ONCOLOGY INC | $678,750 | +26.2% | 75,000 | +50.0% | 0.55% | +9.4% |
IFRX | INFLARX NV | $596,000 | -33.2% | 200,000 | 0.0% | 0.48% | -41.9% | |
RZLT | REZOLUTE INC | $528,000 | -33.3% | 400,000 | 0.0% | 0.43% | -42.0% | |
QIPT | QUIPT HOME MEDICAL CORPcall | $509,000 | -4.7% | 100,000 | 0.0% | 0.41% | -17.1% | |
INBX | INHIBRX INC | $458,750 | -29.3% | 25,000 | 0.0% | 0.37% | -38.6% | |
ELEV | ELEVATION ONCOLOGY INC | $329,510 | -56.4% | 497,299 | 0.0% | 0.27% | -62.1% | |
Exit | AIRSCULPT TECHNOLOGIES INCcall | $0 | – | -75,000 | -100.0% | -0.60% | – | |
AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -100,000 | -100.0% | -1.53% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -240,000 | -100.0% | -1.57% | – |
ETNB | Exit | 89BIO INC | $0 | – | -95,000 | -100.0% | -1.67% | – |
CTLT | Exit | CATALENT INC | $0 | – | -50,000 | -100.0% | -2.01% | – |
PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -342,936 | -100.0% | -2.88% | – |
GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -2.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
TELA BIO INC | 8 | Q3 2023 | 7.6% |
REZOLUTE INC | 8 | Q3 2023 | 1.3% |
OPTINOSE INC | 7 | Q3 2023 | 7.9% |
IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
4 | 2024-02-09 |
SC 13D/A | 2024-02-09 |
SC 13G/A | 2024-01-29 |
13F-HR | 2023-11-13 |
4 | 2023-10-04 |
4 | 2023-08-17 |
SC 13D/A | 2023-08-16 |
13F-HR | 2023-08-11 |
SC 13D/A | 2023-08-03 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.